Cargando…
Individualized Treatment for Advanced Non-Small Cell Lung Cancer: A Case Report and Literature Review
The incidence of lung cancer is high and about 75% of the patients with lung cancer are found in the middle and advanced stage, which has a limited treatment strategy. Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. In this article, we delineate the treatment process o...
Autores principales: | Sun, Qianqian, Li, Weiqing, Liu, Taorui, Guo, Huiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179082/ https://www.ncbi.nlm.nih.gov/pubmed/35692746 http://dx.doi.org/10.3389/fonc.2022.916681 |
Ejemplares similares
-
Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination
por: Wang, Zhenfan, et al.
Publicado: (2021) -
New horizons in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): review of the literature
por: Li, Hao, et al.
Publicado: (2021) -
Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022) -
LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab
por: Wu, Yahua, et al.
Publicado: (2023) -
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022)